Literature DB >> 22133635

Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration.

Carmen Reyes-Cabello1, Francisco Alen, Raquel Gómez, Antonia Serrano, Patricia Rivera, Laura Orio, Fernando Rodríguez de Fonseca, Francisco Javier Pavón.   

Abstract

Endocannabinoids (anandamide and 2-AG) are relevant modulators of appetite and energy expenditure through their action on cannabinoid CB(1) receptors. The actions of anandamide on feeding behavior are dependent both, on the anatomical location of CB(1) receptors (central nervous system versus peripheral tissues) and the feeding status. Anandamide uptake into cells, prior to its degradation by specific enzymatic systems, is a necessary step for the regulation of its extracellular levels. The present study explores the route and feeding stimulus dependency of the effects of the anandamide uptake blocker AM404. Peripherally, AM404 reduced feeding in partially satiated animals through a PPARα-independent mechanism, but not in food deprived ones. When AM404 was injected into the cerebral ventricles of food deprived rats, it resulted in hyperphagia that was antagonized by the cannabinoid receptor inverse agonist SR141716A. These results support the multimodal action of endocannabinoid signaling in feeding regulation, which depends on the anatomical site and the feeding status of the animal.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133635     DOI: 10.1016/j.pbb.2011.11.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Bi-directional modulation of food habit expression by the endocannabinoid system.

Authors:  Carol A Gianessi; Stephanie M Groman; Jane R Taylor
Journal:  Eur J Neurosci       Date:  2019-01-11       Impact factor: 3.386

Review 2.  On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Authors:  Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2021-11-06       Impact factor: 3.911

Review 3.  The Endocannabinoid System and Eating Behaviours: a Review of the Current State of the Evidence.

Authors:  Nathaly Aguilera Vasquez; Daiva E Nielsen
Journal:  Curr Nutr Rep       Date:  2022-08-18

4.  Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.

Authors:  Elżbieta Radziszewska; Ewa Bojanowska
Journal:  Med Sci Monit Basic Res       Date:  2013-01-01

5.  Computational and biological evaluation of N-octadecyl-N'-propylsulfamide, a selective PPARα agonist structurally related to N-acylethanolamines.

Authors:  Inmaculada Moreno-Santos; Francisco Javier Pavón; Miguel Romero-Cuevas; Antonia Serrano; Carolina Cano; Margarita Suardíaz; Juan Decara; Juan Suarez; Fernando Rodríguez de Fonseca; Manuel Macías-González
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

6.  1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats.

Authors:  Estela Castilla-Ortega; Leticia Escuredo; Ainhoa Bilbao; Carmen Pedraza; Laura Orio; Guillermo Estivill-Torrús; Luis J Santín; Fernando Rodríguez de Fonseca; Francisco Javier Pavón
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

Review 7.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

8.  Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite.

Authors:  Adele Romano; Roberto Coccurello; Giacomo Giacovazzo; Gaurav Bedse; Anna Moles; Silvana Gaetani
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411

9.  Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Authors:  Daniel I Brierley; James Samuels; Marnie Duncan; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2016-08-09       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.